BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23715312)

  • 1. [Leprosy reactions in a Colombian national reference centre].
    Nova J; Sánchez G
    Biomedica; 2013; 33(1):99-106. PubMed ID: 23715312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognizing and managing the immunologic reactions in leprosy.
    Kamath S; Vaccaro SA; Rea TH; Ochoa MT
    J Am Acad Dermatol; 2014 Oct; 71(4):795-803. PubMed ID: 24767732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic characteristics of leprosy reactions.
    Scollard DM; Smith T; Bhoopat L; Theetranont C; Rangdaeng S; Morens DM
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):559-67. PubMed ID: 7868954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Necrotizing Erythema Nodosum as a Manifestation of Lepromatous Leprosy Relapse 50 Years after the Initial Infection.
    Galeano J; Contreras A; Pabón L; Ruiz AC; Serrano-Coll H; Arboleda M
    Am J Trop Med Hyg; 2023 Jul; 109(1):53-56. PubMed ID: 37253443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis.
    Santaram V; Porichha D
    Indian J Lepr; 2004; 76(4):310-20. PubMed ID: 16119141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexplained delayed nerve impairment in leprosy after treatment.
    Rosenberg NR; Faber WR; Vermeulen M
    Lepr Rev; 2003 Dec; 74(4):357-65. PubMed ID: 14750581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriological results and leprosy reactions among MB leprosy patients treated with uniform multidrug therapy in China.
    Shen J; Bathyala N; Kroeger A; Arana B; Pannikar V; Mou H; Bao X; Yang R; Manickam P; Li W; Zhou M; Want J
    Lepr Rev; 2012 Jun; 83(2):164-71. PubMed ID: 22997692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leprosy reactions in postelimination stage: the Bangladesh experience.
    Mowla MR; Ara S; Mizanur Rahman AFM; Tripura SP; Paul S
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):705-711. PubMed ID: 27859670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for erythema nodosum leprosum.
    Manandhar R; LeMaster JW; Roche PW
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological characteristics of leprosy reactions: 15 years experience from north India.
    Kumar B; Dogra S; Kaur I
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):125-33. PubMed ID: 15301592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of leprosy reactions in paucibacillary and multibacillary individuals attended at two reference centers in Recife, Pernambuco].
    Teixeira MA; Silveira VM; França ER
    Rev Soc Bras Med Trop; 2010; 43(3):287-92. PubMed ID: 20563498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapses in multibacillary leprosy patients: a retrospective cohort of 11 years in Colombia.
    Guerrero-Guerrero MI; Muvdi-Arenas S; León-Franco CI
    Lepr Rev; 2012 Sep; 83(3):247-60. PubMed ID: 23356026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Delay in leprosy diagnosis as a predictor of disability in a cohort of patients in Colombia, 2000-2010].
    Guerrero MI; Muvdi S; León CI
    Rev Panam Salud Publica; 2013 Feb; 33(2):137-43. PubMed ID: 23525344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histoid leprosy: a retrospective study of 40 cases from India.
    Kaur I; Dogra S; De D; Saikia UN
    Br J Dermatol; 2009 Feb; 160(2):305-10. PubMed ID: 19016704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
    Naafs B
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
    [No Abstract]   [Full Text] [Related]  

  • 18. [Leprosy reactions in discharged patients following cure by multidrug therapy].
    Souza LW
    Rev Soc Bras Med Trop; 2010; 43(6):737-9. PubMed ID: 21181036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lepromatous leprosy in Saudi female from central region.
    al-Majed S
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
    Rodríguez G; Pinto R; López F; Gómez Y
    Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.